Paul Knight
Stock Analyst at Keybanc
(3.26)
# 1,057
Out of 4,502 analysts
122
Total ratings
43.96%
Success rate
2.8%
Average return
Main Sectors:
34 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Overweight | $25 → $28 | $19.85 | +41.06% | 6 | Mar 1, 2024 | |
| RGEN Repligen | Maintains: Overweight | $210 → $220 | $131.39 | +67.44% | 7 | Feb 15, 2024 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $440 → $470 | $323.77 | +45.16% | 10 | Feb 13, 2024 | |
| RVTY Revvity | Maintains: Overweight | $110 → $126 | $111.61 | +12.89% | 2 | Feb 2, 2024 | |
| DHR Danaher | Maintains: Overweight | $260 → $290 | $265.76 | +9.12% | 7 | Feb 1, 2024 | |
| CDMO Avid Bioservices | Maintains: Overweight | $20 → $14 | $9.39 | +49.09% | 5 | Dec 8, 2023 | |
| TECH Bio-Techne | Maintains: Overweight | $115 → $80 | $77.61 | +3.08% | 6 | Nov 1, 2023 | |
| TMO Thermo Fisher | Downgrades: Sector Weight | n/a | $574.73 | - | 6 | Oct 26, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $35 → $37 | $21.75 | +70.11% | 5 | Aug 30, 2023 | |
| TBIO Telesis Bio | Downgrades: Sector Weight | n/a | $4.11 | - | 1 | Aug 11, 2023 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Sector Weight | n/a | $8.28 | - | 8 | Aug 8, 2023 | |
| CYRX Cryoport | Downgrades: Sector Weight | n/a | $8.58 | - | 7 | Jul 17, 2023 | |
| TKNO Alpha Teknova | Initiates: Sector Weight | n/a | $3.27 | - | 1 | Jul 12, 2023 | |
| LAB Standard BioTools | Initiates: Overweight | $4 | $2.25 | +77.78% | 1 | Jul 12, 2023 | |
| A Agilent Technologies | Downgrades: Sector Weight | n/a | $134.16 | - | 7 | May 24, 2023 | |
| AZTA Azenta | Downgrades: Sector Weight | n/a | $56.99 | - | 3 | May 10, 2023 | |
| HBIO Harvard Bioscience | Maintains: Overweight | $5 → $7 | $3.25 | +115.38% | 4 | Apr 26, 2023 | |
| CTLT Catalent | Downgrades: Sector Weight | n/a | $58.40 | - | 5 | Dec 19, 2022 | |
| AVTR Avantor | Maintains: Overweight | $51 → $40 | $22.37 | +78.81% | 5 | Sep 15, 2022 | |
| XGN Exagen | Maintains: Overweight | $20 → $17 | $1.96 | +767.35% | 5 | May 13, 2022 | |
| BLFS BioLife Solutions | Maintains: Overweight | $60 → $30 | $22.35 | +34.23% | 3 | May 10, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $390 → $300 | $222.41 | +34.89% | 1 | May 5, 2022 | |
| IQV IQVIA Holdings | Maintains: Overweight | $290 → $250 | $238.75 | +4.71% | 1 | Apr 28, 2022 | |
| OCX OncoCyte | Downgrades: Sector Weight | n/a | $3.21 | - | 2 | Mar 14, 2022 | |
| TFX Teleflex | Maintains: Overweight | n/a | $224.57 | - | 1 | Jan 8, 2021 | |
| ICUI ICU Medical | Maintains: Overweight | n/a | $125.86 | - | 1 | Jan 8, 2021 | |
| COO The Cooper Companies | Maintains: Overweight | $92 → $99 | $91.99 | +7.62% | 1 | Jan 8, 2021 | |
| AVNS Avanos Medical | Maintains: Overweight | n/a | $22.60 | - | 1 | Jan 8, 2021 | |
| WAT Waters | Initiates: Sector Weight | n/a | $305.31 | - | 3 | Nov 10, 2020 | |
| VCYT Veracyte | Initiates: Sector Weight | n/a | $23.42 | - | 3 | Nov 10, 2020 | |
| SCND Scientific Industries | Initiates: Sector Weight | n/a | $1.70 | - | 1 | Nov 10, 2020 | |
| MLAB Mesa Laboratories | Initiates: Sector Weight | n/a | $108.47 | - | 1 | Nov 10, 2020 | |
| IDXG Interpace Biosciences | Initiates: Buy | n/a | $1.15 | - | 1 | Apr 15, 2020 | |
| ILMN Illumina | Upgrades: Neutral | n/a | $116.29 | - | 1 | Oct 23, 2017 |
Castle Biosciences
Mar 1, 2024
Maintains: Overweight
Price Target: $25 → $28
Current: $19.85
Upside: +41.06%
Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $131.39
Upside: +67.44%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440 → $470
Current: $323.77
Upside: +45.16%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110 → $126
Current: $111.61
Upside: +12.89%
Danaher
Feb 1, 2024
Maintains: Overweight
Price Target: $260 → $290
Current: $265.76
Upside: +9.12%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20 → $14
Current: $9.39
Upside: +49.09%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115 → $80
Current: $77.61
Upside: +3.08%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $574.73
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $21.75
Upside: +70.11%
Telesis Bio
Aug 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $4.11
Upside: -
Maravai LifeSciences Holdings
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $8.28
Upside: -
Cryoport
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $8.58
Upside: -
Alpha Teknova
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.27
Upside: -
Standard BioTools
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $2.25
Upside: +77.78%
Agilent Technologies
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $134.16
Upside: -
Azenta
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $56.99
Upside: -
Harvard Bioscience
Apr 26, 2023
Maintains: Overweight
Price Target: $5 → $7
Current: $3.25
Upside: +115.38%
Catalent
Dec 19, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $58.40
Upside: -
Avantor
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $22.37
Upside: +78.81%
Exagen
May 13, 2022
Maintains: Overweight
Price Target: $20 → $17
Current: $1.96
Upside: +767.35%
BioLife Solutions
May 10, 2022
Maintains: Overweight
Price Target: $60 → $30
Current: $22.35
Upside: +34.23%
Charles River Laboratories International
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $222.41
Upside: +34.89%
IQVIA Holdings
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $238.75
Upside: +4.71%
OncoCyte
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $3.21
Upside: -
Teleflex
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $224.57
Upside: -
ICU Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $125.86
Upside: -
The Cooper Companies
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $91.99
Upside: +7.62%
Avanos Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $22.60
Upside: -
Waters
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $305.31
Upside: -
Veracyte
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $23.42
Upside: -
Scientific Industries
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $1.70
Upside: -
Mesa Laboratories
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $108.47
Upside: -
Interpace Biosciences
Apr 15, 2020
Initiates: Buy
Price Target: n/a
Current: $1.15
Upside: -
Illumina
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $116.29
Upside: -